$3.09
-0.05 (-1.59%)
Cleveland BioLabs, Inc. (NASDAQ:CBLI)
CAPS Rating:
The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.
RSS Headlines
Fool UK